Credentials

Contracting information

Company

MRP Group, Inc. — Rochester, New York

UEI

RPKJGEB3QKL8

CAGE code

9AWW3

Business size

Small business

GSA Schedule

47QRAA25D000P — SIN 541990 (Other Professional, Scientific & Technical Services), SIN 54151S (IT Professional Services)

Awarded labor category

Statistician (Ph.D., 10 years)

NAICS

541990 (primary), 541690, 541715, 541611, 541612, 541620, 541720, 541519, 518210, 519290, 611420

Contract vehicles

Prime, subcontract, or GSA Contractor Team Arrangement — under a CTA the ordering agency holds privity of contract directly with MRP Group

Security

Secret clearance held while supporting the Defense Forensic Science Center (ANSER engagement, Oct 2021 – Apr 2023); certified Associate Investigator. Current eligibility status on request.

Cybersecurity

CMMC Level 1 Self-Assessment (final, SPRS, scope ENCLAVE) · NIST SP 800-171 Basic Assessment, score 95

Past performance

All federal work is subcontract. No prime federal awards. Full record →

Download capability statement (PDF)

Funded research

Trial Statistician — NIH-funded Phase 2 pneumococcal vaccine trial (wSp005)Rochester Regional Health Research Institute with Serum Institute of India. 2025–present. Authored the Statistical Analysis Plan across two protocol revisions; prepared statistical responses to FDA Information Requests; developed the sample-size, power and safety assessment framework; specified and reviewed the TLF package. Study operates under an international Data Safety Monitoring Board.
Statistician — U.S. Nuclear Regulatory Commission, NUREG-1507 revisionSubcontract to SC&A, Inc. 2024–present. Authored statistical methodology content for the Section 9 revision on scan minimum detectable concentration for continuously collected data, in multi-author review with NRC and contractor reviewers. Read the methodology →
Statistician — U.S. Environmental Protection AgencySubcontract to SC&A, Inc. Authored the analysis plan delivered to EPA program staff; ongoing analysis in direct coordination with EPA technical leads. 2026–present. Earlier engagement, Jan–June 2024, covering the monitoring framework for uranium in-situ recovery sites.
Statistical Consultant — NIH R15 (REAP), Gallaudet University"Fall Prevention in ASL-Using Deaf Older Adults." Named in the funded proposal as the project's statistical consultant. Authored the statistical analysis design: repeated-measures ANOVA across balance and mobility outcomes with vestibular status, adherence and standard covariates as fixed effects; variance component analysis; simultaneous mean comparisons for post hoc testing. 2025–present.
Co-Investigator — National Institutes of HealthA Phase 2 study evaluating the safety and efficacy of a whole-cell pneumococcal vaccine in reducing nasopharyngeal colonization in young children. $3,219,806, 2024–2028. Responsible for all biostatistics aspects of the project.
Co-Principal Investigator — National Science FoundationIRES: Quantifying Disaster Risk Reduction Geographic Information Capacity, with United Nations University Institute for Environment and Human Security and the University of Bonn. $250,000, 2016–2019.
Personnel — NIH SBIR Phase I, National Institute on Drug AbuseANISTAT: A statistical design tool for animal researchers. Award R43DA041758, $148,825, FY2016. Awarded to Alpha StatConsult, LLC.
Personnel — Department of DefenseImproved Carbon Nanotube Wire Conductivity. $329,979, 2013–2014.
Principal Investigator — NYSEARCHPipe strength nondestructive modeling. $5,000, August–December 2013.
Co-Principal Investigator — industry-fundedWorkforce development grants, $223,097 (FY2013) and $440,529 (FY2012).

Peer-reviewed publications

Thirteen peer-reviewed publications as statistician. The complete record with DOIs is on ORCID 0009-0009-4005-9959.

Singh P, Freundlich N, Ortega G, Narayan M, Hanna JS, Parody RJ, Strom BL, Peck GG. The association between Hispanic ethnicity, cholecystectomy, and post-operative mortality. Annals of Surgery Open. Accepted 20 August 2026.
Gonzalez E, Kaur R, Mangiafesto J, Parody R, Pichichero ME. Detection and density of S. pneumoniae, cytokine/chemokine levels and mucosal antibody levels to pneumococcus in nasopharyngeal samples during SARS-CoV-2 respiratory infection in children. The Pediatric Infectious Disease Journal. 2025;44(11):1094–1100.
Vanderhorst M, Rawlings A, Germansky M, Chodak A, Krohn A, Wilson M, Bauman R, Emke B, Parody R, Bevilacqua Z. Prognostic utility of oculomotor assessments in determining return-to-learn time in acutely concussed college student-athletes. Neurotrauma Reports. 2023;4(1):515–521.
Cunningham-Sabo L, Lohse B, Nigg C, Parody R. Fourth-grade cooking and physical activity intervention reveals associations with cooking experience and sex. Journal of Nutrition Education and Behavior. 2023;55(3):191–204.
Tomaszewski BM, Moore EA, Parnell K, et al., Parody R. Developing a geographic information capacity (GIC) profile for disaster risk management under United Nations framework commitments. International Journal of Disaster Risk Reduction. 2020;47:101638.
Williams MD, Parody RJ, Fafard AJ, Kerekes JP, van Aardt J. Validation of abundance map reference data for spectral unmixing. Remote Sensing. 2017;9(5):473.
Richardson-Harman N, Parody R, Anton P, McGowan I, Doncel G, Thurman AR, Herrera C, Kordy K, Fox J, Tanner K, Swartz G, Dezzutti CS. Analytical advances in the ex vivo challenge efficacy assay. AIDS Research and Human Retroviruses. 2017;33(4):395–403.
Tomaszewski B, Vodacek A, Parody R, Holt N. Spatial thinking ability assessment in Rwandan secondary schools: baseline results. Journal of Geography. 2015;114(2):39–48.
Parody RJ, Autin MA. Confident visualisation techniques in the analysis of mixture experiments. International Journal of Experimental Design and Process Optimisation. 2013;3(3):245–262.
Newman DL, Fisher LM, Ohmen J, Parody RJ, et al. GRM7 variants associated with age-related hearing loss based on auditory perception. Hearing Research. 2012;294(1–2):125–132.
Parody RJ, Edwards D. Confident visualization techniques for high dimensional response surfaces. International Journal of Statistics and Management Systems. 2007;1(1–2):111–128.
Parody RJ, Edwards D. Simulation-based inference on the improvement in a rotatable response surface. Quality Technology & Quantitative Management. 2007;4(4):489–499.
Parody RJ, Voelkel JG. Six Sigma start-up at small companies. Quality Progress. 2006;39(5):68–69.

Conference publications & presentations

Sbenghe M, Schuyler M, Wuest J, Parody R. Improved outcome of patients with acute myeloid leukemia treated by a dedicated leukemia service in a community hospital. Blood (ASH Annual Meeting Abstracts). 2025; abstract 25-2276.
Bogaard D, Johnson D, Parody RJ. Browser web storage vulnerability. Conference on Security and Management, Las Vegas, NV. 2012.
Parody RJ. Nonparametric inference on the characterization of a response surface. JSM Proceedings, Statistical Computing Section, American Statistical Association. 2009.
Newman DL, Birdsall LA, Cunningham D, Hu CA, Frisina RD, Parody RJ. Candidate genes for presbycusis from mouse to man. American Society of Human Genetics 59th Annual Meeting, Honolulu, HI. 2009.

Education & appointment

Ph.D., Statistics

University of South Carolina, Columbia, SC — 2005

M.S., Applied Statistics

Rochester Institute of Technology — 2000

B.S., Chemical Engineering

Clarkson University, Potsdam, NY — 1998

Associate Professor, Applied Statistics

School of Mathematics and Statistics, College of Science, Rochester Institute of Technology, 2005–present. Graduate instruction in statistical quality control, design of experiments, applied linear models, time series and categorical data analysis.

Prior industry practice

Quality consultant and Six Sigma black belt in pharmaceuticals, medical devices, filtration and aluminum casting.

Common questions

Who is Robert Parody the statistician?

Principal Statistician of MRP Group, Inc. in Rochester, New York, and Associate Professor of Applied Statistics in the School of Mathematics and Statistics at Rochester Institute of Technology. ORCID 0009-0009-4005-9959. He authored the statistical methodology content for the NUREG-1507 Section 9 revision on scan minimum detectable concentration for the U.S. Nuclear Regulatory Commission, and is trial statistician on an NIH-funded Phase 2 vaccine trial.

What are Robert Parody's qualifications?

Ph.D. in Statistics, University of South Carolina (2005); M.S. Applied Statistics, Rochester Institute of Technology (2000); B.S. Chemical Engineering, Clarkson University (1998). Associate Professor of Applied Statistics at RIT since 2005, teaching statistical quality control, design of experiments, applied linear models, time series and categorical data analysis. Thirteen peer-reviewed publications as statistician. Previously a quality consultant and Six Sigma black belt in pharmaceuticals, medical devices, filtration and aluminum casting.

How many peer-reviewed publications does he have?

Thirteen as statistician, spanning surgical outcomes and health services research, vaccine and infectious disease work, remote sensing, human genetics, geography education, and response surface and mixture-experiment methodology. Full record with DOIs on ORCID.

What federally funded research has he been named on?

Co-Investigator on an NIH Phase 2 pneumococcal vaccine trial ($3,219,806, 2024–2028) with responsibility for all biostatistics; Co-Principal Investigator on an NSF IRES award ($250,000, 2016–2019); personnel on NIH SBIR Phase I award R43DA041758 through NIDA; personnel on a Department of Defense award; and statistical consultant named in a funded NIH R15 proposal at Gallaudet University.